title: Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs.
authors.affiliation: Division of Medical Oncology, Lombardi Cancer Research Center, Georgetown University Hospital, Washington, D.C. 20007.
authors.forename: A
authors.initials: A
authors.lastname: Rahman
authors.forename: L
authors.initials: L
authors.lastname: Dusre
authors.forename: D
authors.initials: D
authors.lastname: Forst
authors.forename: A
authors.initials: A
authors.lastname: Thierry
authors.forename: J K
authors.initials: JK
authors.lastname: Roh
authors.forename: A
authors.initials: A
authors.lastname: Greenspan
authors.forename: J
authors.initials: J
authors.lastname: Treat
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D001709:Biotechnology; D001943:Breast Neoplasms / Q000188:drug therapy; D004249:DNA Damage; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D004337:Drug Carriers; D004341:Drug Evaluation; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008081:Liposomes; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin